Zynga: Yeah, Not This Quarter Either

Wall Street consensus had been for Zynga Inc (NASDAQ:ZNGA), already suffering from a plunge in its stock price since its IPO in December 2011, to come in at zero cents per share in earnings for the third quarter. October 4th, however, was “take out the trash day” as the company made three negative announcements. The first was somewhat expected: the (cash!) acquisition of OMGPop, which appears to have come mere weeks before that company’s usership peaked, will be the target of a writedown in the neighborhood of $90 million. The second was the company’s expectation that earnings per share for the third quarter of 2012 would be in the range of zero to a loss of one cent (excluding the OMGPop charge). The third was most worrisome for Zynga followers: estimates of “bookings” (a metric Zynga which believes is more relevant than revenue) for the full year were cut by $100 million, with an expectation that Q3 bookings would be 16% below what the company did in the second quarter of the year. In other words, Zynga is not only at the borderline of profitability; it is currently a shrinking, not growing, business. The takeaway: it is now entirely possible that the best quarter in Zynga’s history will be the six cents per share that it earned in the first quarter of 2012- just three months after the company went public.

Zynga Inc (NASDAQ:ZNGA)

Zynga Inc has been battered by operational changes at Facebook Inc (NASDAQ:FB) which may have reduced traffic to its games (read our analysis of Zynga from summer 2012). At least for now, the sell-side expectation is that the company will recover somewhat and get to six cents per share in earnings next year, yielding a forward P/E of 26. We’re skeptical. Activity in Zynga’s games has been shown to be at best volatile and dependent on temporary highs from the introduction of new games (which means that the company must continue to generate new game ideas that are just as successful as its old ideas just to tread water), and at worst declining. Zynga has also seen considerable insider sales (see a history of insider sales at Zynga) though those aren’t particularly meaningful now as the stock price has fallen so far from where many of these insiders sold.

In the gaming space, we would compare Zynga Inc to Electronic Arts Inc. (NASDAQ:EA) and Activision Blizzard, Inc. (NASDAQ:ATVI) (see our previous article comparing EA to Zynga, Activision, and other peers). The video game industry as a whole has not been doing well recently, and it is showing in the case of these two market leaders: last quarter both saw declines in revenue and earnings compared to the same period in 2011. Activision’s share price is down 11% from a year ago, while EA’s has nearly been cut in half over the same time frame. Both trade at 11 times forward earnings estimates; in EA’s case much of these earnings are expected to come from a rebound in business, and Activision is expected to show substantial earnings growth next year as well. We don’t feel comfortable investing in either company.

Zynga can also be compared to Facebook and to Chinese online game company Changyou.com Limited (NASDAQ:CYOU). These companies’ valuations are very distinct from each other: Facebook trades at 76 times trailing earnings while Changyou’s P/E is only 5. We’d hesitate to call any Chinese company a great value at the moment, as occasionally these companies end up restating their earnings and questions are emerging about the macro economy in the country. Revenue and earnings did show double-digit growth in the company’s most recent quarter over a year earlier, however. Facebook is picking itself up off of its post-IPOs in the teens, currently trading above $21. Its forward multiple is still 35, so we would want to see a stronger indication that its ad sales can drive revenues much higher- or, for that matter, are even effective in the first place- before considering it as a growth stock.

Buying Zynga at this point is a risky move. The company’s profits are now about zero, and its sales appear to be down substantially compared to just three months ago. Its peers don’t look good either- unless an investor wants to take a chance on Changyou- but barring a strategic acquisition Zynga is greatly in need of a turnaround to even justify its current valuation.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!